🇺🇸 isoniazid, rifampin, pyrazinamide in United States

7 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Disease Progression — 1 report (14.29%)
  2. Drug Resistance — 1 report (14.29%)
  3. Haematocrit Decreased — 1 report (14.29%)
  4. Haemoglobin Decreased — 1 report (14.29%)
  5. Meningitis Tuberculous — 1 report (14.29%)
  6. Pulmonary Tuberculosis — 1 report (14.29%)
  7. Red Blood Cell Abnormality — 1 report (14.29%)

Source database →

isoniazid, rifampin, pyrazinamide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is isoniazid, rifampin, pyrazinamide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for isoniazid, rifampin, pyrazinamide in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.